Professor investigates psychiatric medication among incarcerated women

February 24, 2017, Virginia Commonwealth University
Credit: Kia J. Bentley, Ph.D.

Incarcerated women experience mental illness at a disproportionate rate and heavily use psychiatric medication. A new study by Kia J. Bentley, Ph.D., a professor in the School of Social Work, examines this phenomenon, and digs deeper into the incarcerated women's experiences with and beliefs about mental health and psychotropic drugs.

Bentley's study, "Incarcerated Women's Experiences and Beliefs about Psychotropic Medication: An Empirical Study," will be published in a forthcoming edition of the journal Psychiatric Services.

What led you to want to investigate incarcerated women's experiences and beliefs about psychotropic medications?

I have long been interested in and writing about people's experiences with psychotropic medication, especially the meaning that medication has for them. My doctoral advisee, Rachel Casey, came with a longstanding interest and experience in serving incarcerated with mental health challenges. We decided to put our passions together in a project that would build knowledge to help social workers and other providers be more responsive to incarcerated women's mental health needs.

You surveyed 274 women incarcerated at an unnamed correctional facility in the mid-Atlantic region about psychotropic drugs. You also interviewed 25 of those women in more depth. What were some of your findings?

That attitudes and beliefs about psychotropic medication seem to be related to perceptions of its effect on their symptoms and impact on their lives. The good news is that most of the women who participated in our research reported positive effects of medication and a large impact on their lives. Importantly, given the prison context of the research, these women had a surprisingly strong sense of personal agency in decisions to use or not use medication, even with the cautionary note that it takes time and energy to navigate the lengthy trial and error processes to find just the "right" medication and "right" dose. The not-good news is that some of the policies around medication administration (what, when and where medication is distributed), as well as constrained resources, limit access to medications and providers in ways that are experienced as dehumanizing. We also found that trauma and substance use complicate medication use.

What conclusions can we draw from this study?

That taking psychotropic medication is a common and complex phenomenon among incarcerated women. While we know that misuse of medication exists, we should work to affirm their choices to use psychotropic medication when use is freely chosen and perceived as helpful and meaningful. It seems women want to be believed when they say they really need their medication. They don't want others thinking it's a "crutch."

What do you see as the implications of your study's findings?

Mental health providers in forensic settings should intentionally create opportunities for women to tell their story—that is, to share their positive and not-so-positive experiences with the effects and side effects of medication, to offer their views of its importance and impact, and express how they believe use fits into their lives and plays a role in their quality of life and rehabilitation.

Are there reforms with respect to psychotropic medication in jails and prisons that you would recommend?

The hope is that a more comprehensive and nuanced understanding of incarcerated women's experiences might help providers design and deliver more tailored care that compassionately acknowledges their struggle with symptoms and with trauma, especially intentionally including interventions that give voice to their experiences and needs. Obviously all involved in care of women offenders should work to create policies and practices that affirm their choices and humanity, including making a broader array of mental health services available. This would include greater access to individual and group counseling, psychoeducation and skills training programs, as well as specialized interventions to help women cope with trauma and separation from family

How does this study fit into your larger body of research?

Other studies also show the predominance of psychotropic medication as a treatment modality for concerns among offenders. Most of the studies about medication in this population, however, center on adherence. Our mixed method study is one of the largest studies of 's attitudes and beliefs about psychotropic medication in particular and seeks that knowledge through a social science lens of lived experiences.

Anything else you'd like to add?

More research is needed to understand if women's current perceptions of the importance of medication in their lives here is related to limited availability of other forms of care. Our research also suggested more research around women's locus of control and their experiences with stigma.

Explore further: Child mental health care varies widely in primary care settings

More information: Kia J. Bentley et al. Incarcerated Women's Experiences and Beliefs About Psychotropic Medication: An Empirical Study, Psychiatric Services (2016). DOI: 10.1176/appi.ps.201600078

Related Stories

Child mental health care varies widely in primary care settings

April 1, 2016
(HealthDay)—For children aged 4 to 18 years, mental health diagnoses and psychotropic medication prescribing vary across practices in the United States, according to a review published online April 1 in Pediatrics.

Depression lowers women's chances of pregnancy, study finds

May 24, 2016
Women with severe depressive symptoms have a decreased chance of becoming pregnant, while the use of psychotropic medications does not appear to harm fertility, a study by researchers from the Boston University Schools of ...

Women with dementia receive less medical attention

December 5, 2016
Women with dementia have fewer visits to the GP, receive less health monitoring and take more potentially harmful medication than men with dementia, new UCL (University College London) research reveals.

Impact of mental health during pregnancy on infants examined

October 4, 2016
The impact of women's mental health during pregnancy is the focus of a major collaborative study underway in Perth.

Psychotropic drugs commonly prescribed to children with ASD

October 21, 2013
(HealthDay)—Psychotropic medications, singly and in combination, are commonly prescribed for children with autism spectrum disorders (ASD), according to research published online Oct. 21 in Pediatrics.

Recommended for you

Study suggests biological basis for depression, anxiety, sleep disturbances in older adults

October 15, 2018
UC San Francisco researchers, in collaboration with the unique Brazilian Biobank for Aging Studies (BBAS) at the University of São Paulo, have shown that the earliest stages of the brain degeneration associated with Alzheimer's ...

Early changes to synapse gene regulation may cause Alzheimer's disease

October 15, 2018
Alzheimer's disease (AD) is the most common form of dementia, involving memory loss and a reduction in cognitive abilities. Patients with AD develop multiple abnormal protein structures in their brains that are thought to ...

Clues that suggest people are lying may be deceptive, study shows

October 12, 2018
The verbal and physical signs of lying are harder to detect than people believe, a study suggests.

How to avoid raising a materialistic child

October 12, 2018
If you're a parent, you may be concerned that materialism among children has been on the rise. According to research, materialism has been linked to a variety of mental health problems, such as anxiety and depression, as ...

The long-term effects of maternal high-fat diets

October 12, 2018
If a mother eats a high-fat diet, this can have a negative effect on the health of her offspring—right down to her great-grandchildren. This is the conclusion drawn by researchers at ETH Zurich from a study with mice.

Study finds orgasm face and pain face are not the same

October 11, 2018
A team of researchers from the UK and Spain has found evidence showing that contrary to popular belief, the orgasm face is not the same as the pain face. In their paper published in Proceedings of the National Academy of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.